Posted by Michael Wonder on 12 Apr 2023
ICER publishes protocol for annual assessment of drug coverage policies that present barriers to fair access
12 April 2023 - ICER will evaluate whether multiple formularies offered by the five largest US commercial payers, state health exchange plans in the four geographic regions of the US, and the Department of Veterans Affairs provide appropriate access to the prescription drugs reviewed by ICER in 2021.
The Institute for Clinical and Economic Review (ICER) today posted outlining how we will conduct our third annual assessment of how well major insurers’ prescription drug coverage policies align with a set of fair access standards developed by ICER with expert input from patient advocates, clinician specialty societies, payers, pharmacy benefit managers, and life science companies.
